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Urtica atrichocaulis, an endemic plant to China, is commonly used to treat rheumatoid arthritis even though its pharmaceutical
activities and chemical constituents were not studied. Herein, we reported our investigations on the chemical compositions of
the phenolic compounds-rich fraction from U. atrichocaulis (TFUA) and their antirheumatoid arthritis activities. We found that
the TFUA signiﬁcantly inhibited the adjuvant-induced rats arthritis, carrageenin-induced rats paw edema, cotton pellet-induced
mice granuloma, and the acetic acid-induced mice writhing response. Our phytochemical investigations on the TFUA resulted
in the ﬁrst-time isolation and identiﬁcation of 17 phenolic constituents and a bis (5-formylfurfuryl) ether. The extensive HPLC
analysis also revealed the chemical compositions of TFUA. Our further biological evaluation of the main phenolic components,
individually and collectively, indicated that the antirheumatoid arthritis activities of TFUA were the combined eﬀect of multiple
phenolic constituents.
1.Introduction
Rheumatoid arthritis is an immune-related inﬂammation
disorder that aﬀects over 60 million adults in the world
wide. Its predominant symptoms include pain, stiﬀness,
and swelling of peripheral joints. Rheumatoid arthritis may
rapidly progress into a multisystem inﬂammation with ir-
reversible joint destruction and increase the risk of mor-
tality. However, the current treatment medications, such as
nonsteroidal anti-inﬂammatory drugs, glucocorticosteroid,
and immune-depressant are limited for their eﬃcacy and
frequently toxicity. Therefore, more and more patients look
for medical botany options in coping with this debilitating
disease. The recent investigation indicated that an estimated
60–90% of patients with rheumatoid arthritis were very
likely to use botanicals. This growing interest in alternative
medical practices clearly indicates the need for more safety
and eﬀective botanicals [1].
The genus Urtica (Urticaceae Family) is about 30 species
and widely distributes in north and south temperate regions,
also in mountainous areas of tropics [2]. Most species of
genus Urtica are widely used for rheumatism and rheuma-
toid arthritis. Urtica dioica L. and U. urens L. have been used
for arthritis for more than three thousand years in Europe
[3]. In Asia, some Urtica species, such as U. ﬁssa E. Pritz.,
U. laetevirens Maxim., and U. dentata (Hand.-Mazz.) C. J.
Chen, are important herbs for rheumatism and rheumatoid
arthritis [4]. The modern research showed that the aqueous
extract of U. laetevirens Maxim. and U. ﬁssa E. Pritz. had
the potent inhibition of rheumatoid arthritis [5–7]. The
ethanol extract of U. dioica L. signiﬁcantly inhibited the
proinﬂammatory transcription factor NF-κB and the mat-
uration of human myeloid dendritic cells, indicating that it
possessed the therapeutic eﬀect on T-cell-mediated inﬂam-
matory diseases like rheumatoid arthritis [8, 9]. The aqueous
extract of U. macrorrhiza Hand.-Mazz. was reported to ob-
viously suppress the PGE2 release from PMϕ in adjuvant-
induced arthritis rats and the expression of cyclooxygenase-2
(COX-2) mRNA induced by lipopolysaccharide [10].2 Evidence-Based Complementary and Alternative Medicine
Urtica atrichocaulis (Hand.-Mazz.) C. J. Chen is endemic
to China and widely distributed in Guizhou, Sichuan, and
Yunnan provinces [2]. This plant is a perennial herb, up
to 150cm tall, inﬂorescence containing proximal female
ﬂowers and distal male ﬂowers, achene ovoid, smooth, up
to 0.8mm. In traditional chinese medicine, the aerial part of
this plant is a commonly used herb for rheumatoid arthritis,
with a history more than 1000 years. However, its chemical
constituent and pharmacological activity have not been re-
ported yet. We evaluated the antirheumatoid arthritis activ-
ities of diﬀerent fractions and found that the phenolic
compounds-rich fraction from U. atrichocaulis (TFUA) had
the potent activity. In the subsequent investigation of chem-
ical compositions of TFUA, 18 compounds, including 17
phenolic constituents, were isolated. The pharmacological
activitiesofthemainphenolicconstituentswereevaluatedby
adjuvant-induced rats arthritis model. The results suggested
that the multiple phenolic constituents were responsible for
the antirheumatoid arthritis activities of TFUA.
2.MaterialandMethods
2.1. Plant Material and Chemical Agents. Urtica atrichocaulis
wascollectedfromXideCounty,Sichuanprovince(China)in
April 2006, and authenticated by one of authors Professor
Xiaobo Li. A voucher specimen (SJTU 20060419) was de-
posited in School of Pharmacy, Shanghai Jiao Tong Univer-
sity.
Dexamethasone, indometacin, aspirin, morphine, and
CMC were purchased from Shanghai National Pharmaceuti-
cal Co., Ltd (Shanghai, China). Salicylic acid, phaselic acid,
chlorogenic acid, and rutin for pharmacological test were
purchased from Shanghai Ronghe Pharmaceutical Technol-
ogy Development Co., Ltd. (Shanghai, China). Acetonitrile
was HPLC grade from Shanghai Xingke Biochemistry Co.,
Ltd. (Shanghai, China). Carrageenin (type IV) and Freund’s
complete adjuvant agent (FCA) were obtained from Sigma-
Aldrich Corporation (Shanghai, China).
2.2. Experimental Animals. Kunming mice (18–22g) and SD
rats (180–220g) were obtained from Shanghai Laboratory
Animal Center of Chinese Academy of Sciences. They were
acclimatized for 5 days before use and provided food and
water ad libitum. The use of animals in this project was ap-
proved and in compliance with the regulations of the In-
stitutional Animal Care and Use Committee of the School of
Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
2.3. Sample Preparation. The dried aerial part of U. atri-
chocaulis (7.7kg) was extracted under reﬂux with alcohol 2
times for 2h, ﬁltrated, and concentrated in vacuum to give
a greenish-black colored sticky extract (783g). The extract
(721g) was suspended in 2000mL water and sequently frac-
tionated with petroleum ether (boiling range 30∼60◦C) and
ethyl acetate. The ethyl acetate extract was evaporated and
dried in vacuum to yield a yellowish-green extract, which
was named the phenolic compounds-rich fraction from U.
atrichocaulis (TFUA, 137g). For pharmacological test, TFUA
was dissolved in the 0.5% CMC solution.
2.4. Antirheumatoid Arthritis Activities
2.4.1. Adjuvant-Induced Rats Arthritis
Paw Swelling. Adjuvant-induced rats arthritis was induced
according to the method in the literature [11]. In brief, the
right footpad of each male rat was injected subcutaneously
with 0.1mL FCA, containing 10mg heat-inactive BCG in
1.0mL paraﬃn oil. On the 8th day after FCA injection, rats
were randomized in groups and orally given the sample,
dexamethasone, and CMC solution daily for 15 consecutive
days, respectively. The pad thicknesses of the left and right
hind paws were measured before and every other day after
FCAinjectionusingadialthicknessgauge(Mitutoyo,Japan).
The paw swelling at each time point was expressed as an
increase in the footpad thickness (mm).
Arthritis Index. A blinded independent observer with no
knowledge of the treatment protocol performed the arthritis
index evaluation for each rat every other day from the 8th
day after FCA injection. Each noninjected paw was graded
separately from 0 to 4, depending on the severity. The as-
sessmentwasmadeasfollows:0,noresponse;1,slightedema
ofthedigitaljoints;2,edemaofthedigitaljointsandfootpad;
3,grossedemaoftheentirefootpadbelowthejoint;4,edema
of the entire foot. In the case of the more severe responses,
swellingsofthetailandearsalsoweregenerallyobserved,but
no additional score was ascribed for these signs. The arthritis
index for each rat was the sum of the scores of the three
measured joints [12, 13].
2.4.2. Cotton Pellet Granuloma in Mice. Autoclaved cotton
pellets weighing 5.0 ± 0.1mg each were implanted sub-
cutaneously through small incision made along the ﬂank
region of the male mice anesthetized with ether. The mice
were orally administered the sample, dexamethasone, or
CMC solution once daily for seven consecutive days from
the day of cotton pellet insertion. On the 7th day, the
mice were sacriﬁced and the cotton pellets covered by the
granulomatous tissue were excised and dried in hot air oven
at 60◦C till a constant weight was achieved. Granuloma
weight was obtained by subtracting the weight of cotton
pellet on 0 d (before the start of experiment) from the weight
ofthecottonpelletonseventhday(attheendofexperiment)
[14].
2.4.3. Carrageenin-Induced Rats Paw Edema. Male rats were
treatedorallywithsample,indomethacin,andCMCsolution
60min prior to an injection of 0.1mL of 1% carrageenin
sterile (w/v) in saline into the plantar tissue of the right hind
paw. The contralateral hind paws were injected with 0.1mL
of saline as control. Paw pad thickness was measured at 0, 2,
4 and 6h after carrageenin injection, and paw swelling was
obtained by subtracting the right pad thickness from the left
pad thickness [12].Evidence-Based Complementary and Alternative Medicine 3
2.4.4. Acetic Acid-Induced Mice Writhing Response. Mice
were kept singly in a clear plastic observational cage
(35cm × 25cm × 15cm) and were pretreated with sample,
aspirin or CMC solution by intragastric administration 60
min prior to intraperitoneal injection of 0.6% acetic acid in
a volume of 0.1mL per mouse. After the injection of acetic
acid, the number of writhes exhibited for15min were count-
ed. The percent inhibition was calculated as follows [15]:
%inhibition =
mean writhes of vehicle group −mean writhes of test group
mean writhes of vehicle group
×100. (1)
2.4.5. Mice Hot-Plate Test. Female mice were placed on an
YLS-6A intelligent hot-plate apparatus (Shandong Academy
of Medical Sciences, China). The temperature of metal sur-
facewasmaintainedat55.0 ± 0.5◦C.Latencytoadiscomfort
reaction (licking hind paw) was taken as pain threshold in
mice and a cut-oﬀ time of 60 seconds was maintained to
prevent scald. The ﬁfty valid mice were selected (the pain
threshold was determined in 5 to 30 seconds) and divided
into ﬁve groups randomly. The deferent groups of mice were
orally administered the sample, CMC solution, or intraperi-
toneally injected morphine. The pain threshold was deter-
mined before and 30, 60, 90, and 120min after administra-
tion, respectively [16].
2.5. Statistical Analysis. Data were expressed as mean ±
standard deviation (SD). Diﬀerences between groups were
evaluated by Kruskal-Wallis test for the arthritic scores, or
one-way analysis of variance (ANOVA) followed by Dun-
nett’s test for the others indices with the aid of SPSS11.5
software package. Statistical signiﬁcance is expressed as
∗P < 0.05, ∗∗P < 0.01.
3. Chemical Compositions Analysis
3.1. Isolation and Structure Identiﬁcation of Compounds in
TFUA. TFUA was fractionated by silica gel (200–300 mesh,
Qingdao Haiyang chemical Co., Ltd.) column chromatogra-
phy and gradually eluted with dichloromethane-methanol.
The fractions obtained were further puriﬁed by repeat silica
gel and Sephadex LH-20 (Pharmacia) column chromatogra-
phy to yield pure compounds.
Compound identiﬁcation was carried out by determina-
tion spectra data. The 1H (400MHz) and 13C (100MHz)
NMR data were obtained with the solvent as reference, em-
ploying Bruker Avance 400 spectrometers. Molecular weight
was obtained on Finnigan/MAT 4510 mass spectrometer.
Optical rotation values were determined with a JASCO Dip-
360 digital polarimeter.
3.2. Chemical Analysis of TFUA. Chemical analysis of TFUA
was performed with an Agilent 1200 liquid chromatograph
equipped with a DAD detector, quaternary pump, on-line
degasser, autosampler, and thermostatic column compart-
ment. Phenolic compounds were separated on an Agilent
Zorbax Elipse XDB-C18 column (5μm, 250 × 4.6mm).
Then the contents of main constituents in TFUA were cal-
culated using their standards.
0
2
4
6
8
10
12
Vehicle Dexamethasone
(10mg/kg)
TFUA
(50mg/kg)
TFUA
(150mg/kg)
D
r
y
w
e
i
g
h
t
o
f
g
r
a
n
u
l
o
m
a
(
m
g
)
∗∗
∗
∗∗
Figure 1: Eﬀect of phenolic compounds-rich fraction from Urtica
atrichocaulis (TFUA) on the weight of cotton pellet-induced gran-
uloma in mice. Values are expressed as mean ± SD. N = 10.
∗P < 0.05, ∗∗P < 0.01 compared with vehicle control.
4. Results
4.1. Antirheumatoid Arthritis Eﬀects of TFUA. TFUA showed
the obvious therapeutic eﬀect on the adjuvant-induced ar-
thritis. It could signiﬁcantly inhibit the paw swell induced by
FCA and decreased the arthritis index, indicating it can in-
hibit the primary inﬂammation and second inﬂammation
(Table 1). So its other pharmacological activities related to
antirheumatoid arthritis, such as inhibiting nonspeciﬁc in-
ﬂammation and analgesic activities, were warranted to the
further evaluation.
The inhibiting activity of nonspeciﬁc inﬂammation was
evaluatedby themodels of mice cottonpellet granuloma and
carrageenin-induced rats paw edema. The results showed
that TFUA had the moderate anti-inﬂammatory activity. It
could inhibit the granuloma hyperplasia caused by cotton
pellet at the dosages of 50 and 150mg/kg (Figure 1). TFUA
could reduce the carrageenin-induced rat paw edema also,
and this activity became obvious at 4h after administration
(Table 2).
The analgesic activity of TFUA was evaluated by the mice
models of acetic acid-induced writhing response and hot-
plate test. The results of acetic acid-induced writhing re-
sponse revealed that TFUA had the obviously analgesic
activity. It could signiﬁcantly decrease the number of writhes
induced by acetic acid (Table 3). However, the obvious anal-
gesic activity of TFUA was not observed in the hot-plate test4 Evidence-Based Complementary and Alternative Medicine
T
a
b
l
e
1
:
E
ﬀ
e
c
t
o
f
p
h
e
n
o
l
i
c
c
o
m
p
o
u
n
d
s
-
r
i
c
h
f
r
a
c
t
i
o
n
f
r
o
m
U
r
t
i
c
a
a
t
r
i
c
h
o
c
a
u
l
i
s
(
T
F
U
A
)
o
n
F
C
A
-
i
n
d
u
c
e
d
r
a
t
s
a
r
t
h
r
i
t
i
s
.
G
r
o
u
p
D
o
s
e
(
m
g
/
k
g
)
P
a
w
s
w
e
l
l
(
m
m
)
A
r
t
h
r
i
t
i
s
i
n
d
e
x
1
2
d
1
6
d
2
0
d
1
2
d
1
6
d
2
0
d
R
L
R
L
R
L
V
e
h
i
c
l
e
—
4
.
2
1
±
0
.
8
4
3
.
5
2
±
1
.
0
1
3
.
8
6
±
0
.
7
2
3
.
6
3
±
0
.
7
1
3
.
4
7
±
0
.
4
5
3
.
2
9
±
0
.
7
3
7
.
6
±
2
.
1
9
.
9
±
2
.
6
1
0
.
3
±
1
.
9
D
e
x
a
m
e
t
h
a
s
o
n
e
3
0
3
.
3
4
±
0
.
6
6
∗
2
.
6
1
±
0
.
7
6
∗
3
.
0
9
±
0
.
5
6
∗
2
.
5
2
±
0
.
7
6
∗
∗
2
.
8
8
±
0
.
2
7
∗
∗
2
.
0
7
±
0
.
6
2
∗
∗
5
.
2
±
2
.
3
∗
4
.
4
±
1
.
8
∗
∗
3
.
5
±
2
.
7
∗
∗
T
F
U
A
5
0
3
.
7
7
±
0
.
7
5
3
.
0
7
±
0
.
9
4
3
.
6
1
±
0
.
6
2
2
.
8
2
±
0
.
9
7
∗
3
.
0
2
±
0
.
4
6
∗
2
.
5
2
±
0
.
5
6
∗
7
.
1
±
1
.
9
8
.
7
±
1
.
5
8
.
4
±
2
.
3
1
5
0
3
.
5
1
±
0
.
6
1
∗
2
.
8
9
±
0
.
8
5
∗
3
.
2
0
±
0
.
6
7
∗
2
.
7
7
±
0
.
8
5
∗
2
.
8
1
±
0
.
6
1
∗
2
.
2
7
±
0
.
6
8
∗
∗
6
.
5
±
2
.
0
7
.
8
±
1
.
5
∗
7
.
6
±
2
.
2
∗
V
a
l
u
e
s
a
r
e
e
x
p
r
e
s
s
e
d
a
s
m
e
a
n
±
S
D
.
N
=
1
0
.
∗
P
<
0
.
0
5
,
∗
∗
P
<
0
.
0
1
c
o
m
p
a
r
e
d
w
i
t
h
v
e
h
i
c
l
e
c
o
n
t
r
o
l
.Evidence-Based Complementary and Alternative Medicine 5
Table 2: Eﬀect of phenolic compounds-rich fraction from Urtica atrichocaulis (TFUA) on rats paw edema induced by carrageenin.
Group Dose (mg/kg)
Paw swell (mm)
2h 4h 6h
Vehicle — 4.72 ± 0.88 5.15 ± 1.06 4.93 ± 0.92
Indometacin 30 3.78 ± 0.93∗ 3.22 ± 0.73∗∗ 2.37 ± 0.95∗∗
TFUA 50 4.42 ± 1.26 4.08 ± 0.95∗ 3.69 ± 0.71∗
150 4.38 ± 0.65 3.64 ± 0.78∗∗ 3.20 ± 0.83∗∗
Values are expressed as mean ± SD. N = 10. ∗P < 0.05, ∗∗P < 0.01 compared with vehicle control.
Table 3: Eﬀect of phenolic compounds-rich fraction from Urtica atrichocaulis (TFUA) on the mice writhes induced by acetic acid.
Group Dose (mg/kg) Number of writhes in 15min Inhibition rate (%)
Vehicle — 29.5 ± 8.4 —
Aspirin 150 14.3 ± 4.8∗∗ 51.5
TFUA 50 20.5 ± 6.4∗∗ 30.5
150 11.7 ± 3.2∗∗ 63.4
Values are expressed as mean ± SD. N = 10. ∗P < 0.05, ∗∗P < 0.01 compared with vehicle control.
(Table 4). These results indicated that TFUA inhibited the
inﬂammatory pain rather than neuropathic pain.
4.2. Isolation and Structure Identiﬁcation of Compounds in
TFUA. TFUA (83g) was fractionated by silica gel column
chromatography and gradually eluted with dichlorometh-
ane-methanol (95:5–60:40) to give 76 fractions of 500mL
each. These fractions were puriﬁed by repeat silica gel and
sephadexLH-20columnchromatographyandresultedinthe
isolation of 18 compounds (Figure 2). Their spectral data
were as the following:
Bis (5-formylfurfuryl) ether (1, 13mg). Colorless needle
(chloroform); HR EI-MS m/z: 234.0532, calcd for C12H10O5,
234.0528. 1Ha n d13C-NMR spectral data were consistent
with those reported in the literature [17].
Scopoletin (2, 8mg). Colorless needle (MeOH). 1Ha n d13C-
NMRspectraldatawereconsistentwiththosereportedinthe
literature [18].
(–) Olivil (3, 6mg). Colorless powder (MeOH); [α]
20
D −43.5◦
(c = 1.0, CHCl3). 1Ha n d13C-NMR spectral data were con-
sistent with those reported in the literature [19].
(–) Secoisolariciresinol (4, 11mg). Colorless powder
(MeOH). [α]
20
D −21.3◦ (c = 1.0, MeOH). 1H-NMR (CD3OD,
400MHz) δ:6 . 6 4( 2 H ,d ,J = 1.8Hz, H-2, 2 ), 6.69 (2H,
d, J = 8.0Hz, H-5, 5 ), 6.58 (2H, dd, J = 1.8, 8.0Hz, H-6,
6 ), 2.67 (2H, dd, J = 7.0, 13.8Hz, H-7a, 7 a), 2.59 (2H, dd,
J = 7.0,13.8Hz,H-7b,7 b),1.92(2H,m,H-8,8  ),3.61(2H,
m, H-9, 9 ), 3.75 (6H, s, 2 × OCH3); 13C NMR (CD3OD,
100 MHz) δ: 134.2 (C-1, 1 ), 114.0 (C-2, 2 ), 149.1 (C-3, 3 ),
145.7 (C-4, 4 ), 116.0 (C-5, 5 ), 123.0 (C-6, 6 ), 36.3 (C-7,
7 ), 44.5 (C-8, 8 ), 62.4 (C-9, 9 ), 56.1 (2 × OCH3)[ 20].
(–) Matairesinol (5, 8mg). Colorless powder (MeOH).
[α]
20
D −37.0◦ (c = 1.0, CHCl3). 1Ha n d13C-NMR spectral
data were consistent with those reported in the literature
[21].
Ferulic Acid (6, 5mg). Colorless styloid (MeOH); EI-MS
m/z: 194 (M+); 1Ha n d13C-NMR spectral data were
consistent with those reported in the literature [22].
p-Coumaric Acid (7, 10mg). Colorless needle (acetone); 1H
and 13C-NMR spectral data were consistent with those
reported in the literature [22].
Caﬀeic Acid (8, 7mg). Yellowish needle (MeOH). 1Ha n d
13C-NMR spectral data were consistent with those reported
in the literature [23].
Protocatechuic Aldehyde (9, 14mg). Colorless needle
(MeOH); 1Ha n d13C-NMR spectral data were consistent
with those reported in the literature [24].
Salicylic Acid (10, 33mg). Colorless needle (MeOH); 1Ha n d
13C-NMR spectral data were consistent with those reported
in the literature [25].
Luteolin (11, 6mg). Yellow needle (MeOH); 1Ha n d13C-
NMRspectraldatawereconsistentwiththosereportedinthe
literature [26].
Quercetin (12, 15mg). Yellow needle (MeOH); 1Ha n d13C-
NMRspectraldatawereconsistentwiththosereportedinthe
literature [18].6 Evidence-Based Complementary and Alternative Medicine
Table 4: Eﬀect of phenolic compounds-rich fraction from Urtica atrichocaulis (TFUA) on the mice pain induced by hot-plate.
Group Dose (mg/kg) Anterior pain
threshold (s)
Posterior pain threshold (s)
30 60 90 120
Vehicle — 18.0 ± 3.5 20.1 ± 5.7 21.5 ± 5.6 21.2 ± 6.7 19.9 ± 8.1
Morphine 30 18.5 ± 3.5 30.4∗∗ ± 3.8 35.0∗∗ ± 6.0 28.6∗∗ ± 4.1 27.4∗∗ ± 4.6
TFUA 50 19.4 ± 3.8 21.6 ± 5.5 23.2 ± 6.1 21.7 ± 7.2 21.3 ± 8.8
150 19.0 ± 3.7 21.2 ± 5.4 22.7 ± 5.9 21.4 ± 7.0 22.0 ± 8.5
Values are expressed as mean ± SD. N = 10. ∗P < 0.05, ∗∗P < 0.01 compared with vehicle control.
Table 5:Thecontentdeterminationresultsofphenoliccompounds-richfractionfromUrticaatrichocaulis(TFUA)byHPLCanalysis(mg/g).
Phenolic acids Flavonoids The others
Chlorogenic acid 88.3 Rutin 124.1 Secoisolariciresinol 37.5
Phaselic acid 62.4 Quercetin 30.9 Scopoletin 21.6
Salicylic acid 52.9 Luteolin 4.4
Caﬀeic acid 17.6
Protocatechuic aldehyde 10.3
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Figure 3: HPLC proﬁle of phenolic compounds-rich fraction
from Urtica atrichocaulis (TFUA). The concentration of TFUA was
1.0mg/mL and injection volume was 10μL. The detection wave-
length was set at 280nm and the column was thermostated at 30◦C.
The eluent was H2O (containing 0.1% acetic acid)/acetonitrile.
A linear gradient solvent system was used, starting from 95%
H2O to 100% acetonitrile during a 40-min period, at the ﬂow
rate of 0.8mL/min. 1: protocatechuic aldehyde; 2: caﬀeic acid;
3: chlorogenic acid; 4: secoisolariciresinol; 5: rutin; 6: phaselic
acid; 7: kaempferol-3-O-rutinoside + kaempferol 3, 7-di-O-rham-
nopyranoside; 8: salicylic acid; 9: scopoletin; 10: ferulic acid +
gossypetin; 11: quercetin; 12: luteolin.
Gossypetin (13, 6mg). Yellow needle (MeOH); 1Ha n d13C-
NMRspectraldatawereconsistentwiththosereportedinthe
literature [27].
Kaempferol-3-O-rutinoside (14, 23mg). Yellow granule
(MeOH); 1Ha n d13C-NMR (CDCl3, 100MHz) spectral data
were consistent with those reported in the literature [28].
Rutin (15, 57mg). Yellow powder (MeOH); 1Ha n d13C-
NMR spectral data agreed with those reported in the liter-
ature [29].
Kaempferol 3, 7-di-O-rhamnopyranoside (16, 10mg). Yellow
needle (MeOH); 1H-NMR (CD3OD, 400MHz) δ:7 . 8 0( 2 H ,
d, J = 8.7Hz, H-2 ,6  ), 6.94 (2H, d, J = 8.7Hz, H-3 ,5  ),
6.75 (1H, d, J = 2.0Hz, H-8), 6.48 (1H, d, J = 2.0Hz, H-6),
5.06 (1H, d, J=2.0Hz, 3-rha H-1), 5.04 (1H, d, J = 2.0Hz,
7-rha H-1), 1.25 (3H, d, J = 6.1Hz, 7-rha-Me), 0.93 (3H,
d, J = 5.5Hz, 3-rha -Me); 13C-NMR (CD3OD, 100MHz) δ:
158.1 (C-2), 136.5 (C-3), 179.8 (C-4), 163.1 (C-5), 99.9 (C-
6), 163.6 (C-7), 95.6 (C-8), 161.1 (C-9), 107.6 (C-10), 122.4
(C-1 ), 132.0 (C-2 ,6  ), 116.6 (C-3 ,5  ), 161.8 (C-4 ). 3-rha:
103.5 (C-1), 72.1 (C-2), 73.2 (C-3), 73.6 (C-4), 71.9 (C-5),
18.1 (C-6); 7-rha: 100.6 (C-1), 71.7 (C-2), 72.1 (C-3), 73.6
(C-4), 71.3 (C-5), 17.7 (C-6) [30].
Phaselic Acid (17, 28mg). Yellow needle (MeOH); [α]
20
D +
34.8◦ (c = 2.0, H2O). 1H-NMR (CD3OD, 400MHz): 6.96
(1H, d, J = 8.0Hz, H-5), 7.14 (1H, brd, J = 8.0Hz, H-6),
7.22(1H,brs,H-2),7.68(1H,d,J = 16.0Hz,H-7),6.44(1H,
d, J = 16.0Hz, H-8), 5.16 (1H, dd, J = 2.8, 11.2 Hz, H-2 ),
2.84(1H,dd,J = 2.8,15.6Hz,H-3 a),2.65(1H,dd,J = 11.2,
15.6Hz,H-3 b); 13C-NMR(CD3OD,100MHz):147.6(C-1),
146.7 (C-7), 144.6 (C-2), 127.8 (C-5), 123.4 (C-4), 116.8 (C-
8), 115.7 (C-3), 115.1 (C-6), 178.8 (C-1 ), 74.2 ( C-2 ), 40.2
(C-3 ), 178.0 (C-4 )[ 31].
Chlorogenic Acid (18, 33mg). Colorless needle (MeOH); 1H
and 13C-NMRspectraldataagreedwiththosereportedinthe
literature [32].
4.3. HPLC Analysis of TFUA. The chemical compositions of
TFUA were further investigated by HPLC analysis. The re-
sults showed that phenolic acids and ﬂavonoids were the
main constituents. The relatively rich phenolics (contents
above 5 percent) included rutin, chlorogenic acid, phaselic
acid, and salicylic acid (Figure 3,T a b l e5).
4.4. The Antirheumatoid Arthritis Activities of the Main Phe-
nolic Compounds and Their Combination. In order to screen
the antirheumatoid arthritis constituents in TFUA, the
pharmacological activities of the main phenolic acids, ﬂa-
vanoids, and their combination (the ratio was based on
their contents in TFUA) were evaluated by FCA-induced rats
arthritis model. The phenolic acids exhibited the statistically
signiﬁcant inhibition of edema in the injected paw (primary
response) at dose levels of 50mg/kg orally, when compared
withz the vehicle control group. Rutin showed moderate ac-
tivity of inhibition of edema in the uninjected paw (second
response). It is noted that neither phenolic acids nor ﬂa-
vanoids exhibited the signiﬁcant suppressive eﬀect on both
primary swelling and second pathological changes of the
experimental rats. However, their combination showed the
obvious inhibition activity of paw edema in both the injected
paw and the uninjected paw (Table 6). So, the antirheuma-
toid arthritis activity of TFUA may be the combined action
of phenolic acids and ﬂavanoids.
5. Discussion
It is well known that salicylic acid and its derivative aspirin
had the anti-inﬂammatory and analgesic activity and often
used to cure rheumatoid arthritis. However, these constit-
uents only inhibit primary response, do not aﬀect the sec-
ond response and immune function, which is similar with
the result of the present study. Although immunosuppressive
agentandglucocorticosteroidinhibitsecondaryprocess,they
have obvious side eﬀect and toxicity. So the exploit of the
antirheumatoid arthritis agent which could inhibit both the
primary and secondary process, and possess good eﬀect
and lower toxicity from medical plant, had drawn much
attention.
Urtica atrichocaulis has been used as antirheumatoid
herb in China for a long time and no obvious toxicity has
been reported. In order to screen for its antirheumatoid
arthritisfraction,theanti-inﬂammatoryactivityofthreepar-
tition fractions, that is, petroleum ether fraction, ethyl ac-
etate fraction, and water layer fraction from alcohol extract
were evaluated by the adjuvant-induced rat arthritis model.
The results showed that TFUA inhibited both primary and
secondary processes and showed the potent activity of anti-
nonspeciﬁc inﬂammation and analgesic activities (Table 1);
however, the petroleum ether fraction and water layer frac-
tion did not show the obvious activity (data not given).8 Evidence-Based Complementary and Alternative Medicine
T
a
b
l
e
6
:
T
h
e
a
n
t
i
r
h
e
u
m
a
t
o
i
d
a
r
t
h
r
i
t
i
s
a
c
t
i
v
i
t
i
e
s
o
f
t
h
e
m
a
i
n
p
h
e
n
o
l
i
c
c
o
m
p
o
u
n
d
s
a
n
d
t
h
e
i
r
c
o
m
b
i
n
a
t
i
o
n
.
G
r
o
u
p
D
o
s
e
(
m
g
/
k
g
)
P
a
w
s
w
e
l
l
(
m
m
)
A
r
t
h
r
i
t
i
s
i
n
d
e
x
1
2
d
1
6
d
2
0
d
1
2
d
1
6
d
2
0
d
R
L
R
L
R
L
V
e
h
i
c
l
e
—
4
.
4
5
±
0
.
9
3
3
.
8
0
±
0
.
6
1
4
.
1
6
±
0
.
8
9
4
.
0
3
±
0
.
7
7
3
.
8
9
±
0
.
5
4
3
.
5
7
±
0
.
6
1
8
.
5
±
2
.
3
1
0
.
8
±
1
.
7
1
1
.
1
±
2
.
4
D
e
x
a
m
e
t
h
a
s
o
n
e
3
0
3
.
3
3
±
0
.
6
5
∗
3
.
0
9
±
0
.
8
7
∗
2
.
9
2
±
0
.
7
2
∗
∗
2
.
8
4
±
0
.
4
7
∗
∗
2
.
2
3
±
0
.
4
2
∗
∗
2
.
2
4
±
0
.
5
8
∗
∗
6
.
2
±
1
.
7
∗
4
.
9
±
1
.
8
∗
∗
3
.
7
±
2
.
7
∗
∗
S
a
l
i
c
y
l
i
c
a
c
i
d
5
0
3
.
5
7
±
0
.
8
9
∗
3
.
6
7
±
0
.
7
9
3
.
3
4
±
0
.
5
6
∗
3
.
5
1
±
0
.
8
3
2
.
9
5
±
0
.
6
1
∗
3
.
2
5
±
0
.
4
3
7
.
7
±
2
.
8
1
0
.
1
±
2
.
5
9
.
8
±
1
.
7
P
h
a
s
e
l
i
c
a
c
i
d
5
0
3
.
8
8
±
0
.
8
9
3
.
5
2
±
0
.
8
5
3
.
0
9
±
0
.
6
7
∗
∗
3
.
6
2
±
0
.
5
3
2
.
7
1
±
0
.
4
9
∗
∗
3
.
2
8
±
0
.
7
3
6
.
9
±
2
.
6
9
.
8
±
1
.
7
1
0
.
4
±
2
.
1
C
h
l
o
r
o
g
e
n
i
c
a
c
i
d
5
0
4
.
2
1
±
0
.
6
6
3
.
5
5
±
0
.
4
4
3
.
7
3
±
0
.
7
5
3
.
6
6
±
0
.
5
9
3
.
5
6
±
0
.
8
5
3
.
3
9
±
0
.
7
6
8
.
1
±
2
.
5
1
0
.
3
±
1
.
7
1
0
.
8
±
2
.
3
R
u
t
i
n
5
0
4
.
3
6
±
0
.
8
0
3
.
4
0
±
0
.
6
7
3
.
9
2
±
0
.
5
4
3
.
2
9
±
0
.
4
7
∗
3
.
7
8
±
0
.
9
2
2
.
8
3
±
0
.
8
7
∗
7
.
6
±
2
.
0
9
.
3
±
1
.
3
8
.
7
±
1
.
9
∗
C
o
m
b
i
n
a
t
i
o
n
a
5
0
3
.
4
8
±
0
.
7
2
∗
3
.
2
1
±
0
.
5
8
∗
3
.
4
0
±
0
.
7
1
∗
3
.
0
4
±
0
.
5
5
∗
∗
2
.
8
4
±
0
.
6
5
∗
∗
2
.
6
1
±
0
.
7
7
∗
∗
7
.
2
±
1
.
8
9
.
0
±
1
.
9
∗
8
.
2
±
1
.
5
∗
V
a
l
u
e
s
a
r
e
e
x
p
r
e
s
s
e
d
a
s
m
e
a
n
±
S
D
.
N
=
1
0
.
∗
P
<
0
.
0
5
,
∗
∗
P
<
0
.
0
1
c
o
m
p
a
r
e
d
w
i
t
h
v
e
h
i
c
l
e
c
o
n
t
r
o
l
.
a
T
h
e
r
a
t
i
o
o
f
r
u
t
i
n
:
c
h
l
o
r
o
g
e
n
i
c
a
c
i
d
:
p
h
a
s
e
l
i
c
a
c
i
d
:
s
a
l
i
c
y
l
i
c
a
c
i
d
i
n
c
o
m
b
i
n
a
t
i
o
n
w
a
s
1
2
:
9
:
6
:
5
,
a
c
c
o
r
d
i
n
g
t
o
t
h
e
i
r
c
o
n
t
e
n
t
s
i
n
p
h
e
n
o
l
i
c
c
o
m
p
o
u
n
d
s
-
r
i
c
h
f
r
a
c
t
i
o
n
f
r
o
m
U
r
t
i
c
a
a
t
r
i
c
h
o
c
a
u
l
i
s
(
T
F
U
A
)
.Evidence-Based Complementary and Alternative Medicine 9
SothechemicalcompositionsofTFUAwerewarrantedtothe
systemic investigation.
In order to elucidate the constituents in TFUA, the sys-
temic isolation of TFUA was carried out. As a result, eight-
een compounds were isolated, of which the phenolic acids
and ﬂavanoids were the main constituents (Figure 3). Subse-
quently, the contents of the main constituents of TFUA were
determined by HPLC. The result showed that chlorogenic
acid, phaselic acid, rutin, and salicylic acid were the main
phenolic constituents (Figure 3,T a b l e5).
In order to investigate the active constituents of TFUA,
the antirheumatoid arthritis actions of main phenolic con-
stituents were further evaluated. The results suggested that
the main phenolic acids (chlorogenic acid, phaselic acid, and
salicylic acid) in TFUA inhibited the primary response; the
main ﬂavanoids (rutin) inhibited the second response. The
antirheumatoid arthritis of TFUA may be the combined
action of multiple phenolic constituents.
Some phenolics were reported to possess the therapeutic
eﬀect on rheumatoid arthritis. Salicylic acid and its derivates
had the potent anti-inﬂammatory activity and analgesic ac-
tivity and usually used for rheumatoid arthritis patients to
relieve the joint inﬂammation and pain. Recent research re-
portedthatscopoletinhadgoodanalgesicactivity[33];quer-
cetin, rutin, and kaempferol-3-O-rutinoside had the im-
mune modulation and antirheumatoid arthritis action, they
reduce adjuvant-induced arthritis clinical signs and decrease
human macrophage-derived inﬂammatory mediators [34–
36]; kaempherol-3-O-rutinoside had the immunostimula-
tory activity and could possibly be useful for treating
patients suﬀering from chronic granulomatous diseases [37].
Caﬀeic acid showed the powerful inhibitory eﬀects on os-
teoclastogenesis and signiﬁcantly suppressed expression of
NFATc1 in adjuvant-induced arthritis rats [38]. The present
study revealed that TFUA contained a high level of rutin,
salicylic acid, caﬀeic acid, scopoletin, and quercetin. So, the
antirheumatoid arthritis activity of U. atrichocaulis is very
likely to be the combined action of multiple phenolic com-
pounds.
6. Conclusions
In conclusion, the phenolic compounds-rich fraction from
Urtica atrichocaulis inhibit the experimental arthritis in-
duced by FCA and its activity may be the combined ef-
fect of multiple phenolic compounds. The antirheumatoid
arthritis eﬀects observed in vivo may give an explanation
for the clinical application of U. atrichocaulis in therapy of
rheumatoid diseases.
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